Primary Job Title President and Chief Executive Officer Primary Organization MacRegen
Location Birmingham, Alabama, United States Regions Southern US Gender Male
LinkedIn View on LinkedIn
Dr. Silber is Professor of Neurology and Bioengineering and Therapeutic Sciences at the University of California San Francisco School of Medicine, and Chief of Drug Discovery R & D at the Institute for Neurodegenerative Diseases. He has held senior executive positions in several of the world's leading Pharma/Biotech companies,
including most recently as Senior Vice President and Site Head of Preclinical R&D at Roche Pharmaceuticals. He has experience developing innovative new medicines in major diseases and has expertise in root cause analysis of R&D attrition/success. Dr. Silber has published over 125 research articles, book chapters, and abstracts, and is a member of the editorial boards for six journals. He has also held other key positions, including Vice President of R&D at J&J/ALZA; Director of Genomic and Proteomic Sciences at Pfizer Research; Senior Director and Division Head of Pharmacology and Toxicology and Early Clinical Development at Cetus (Novartis); Director and Head of Drug Metabolism at Lederle (Pfizer); and Assistant Professor, University of Washington School of Medicine and Pharmacy. He continues to be involved in four biotechnology companies as an SAB member, as an acting CSO, and is an advisor to Pharma/Biotech Presidents and Venture Capital companies. Dr. Silber has a PhD in Pharmaceutical Chemistry and Pharmacology from the University of California, San Francisco.
